Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Dow
Merck
AstraZeneca
Johnson and Johnson
Mallinckrodt
Daiichi Sankyo
Covington
Medtronic

Generated: June 20, 2018

DrugPatentWatch Database Preview

Pancuronium bromide - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for pancuronium bromide and what is the scope of pancuronium bromide patent protection?

Pancuronium bromide
is the generic ingredient in two branded drugs marketed by Elkins Sinn, Hospira, Igi Labs Inc, Teva Pharms Usa, and Organon Usa Inc, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for pancuronium bromide. One supplier is listed for this compound.
Pharmacology for pancuronium bromide
Medical Subject Heading (MeSH) Categories for pancuronium bromide
Synonyms for pancuronium bromide
(2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)-2,16-bis(1-methylpiperidinium-1-yl)androstane dibromide
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate dibromide
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate bromide
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate dibromide
1-[(1S,2S,4S,5S,7S,10R,11S,13S,14R,15S)-5,14-bis(acetyloxy)-2,15-dimethyl-13-(1-methylpiperidin-1-ium-1-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-4-yl]-1-methylpiperidin-1-ium
1-[(1S,2S,4S,5S,7S,10R,11S,13S,14R,15S)-5,14-BIS(ACETYLOXY)-2,15-DIMETHYL-13-(1-METHYLPIPERIDIN-1-IUM-1-YL)TETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECAN-4-YL]-1-METHYLPIPERIDIN-1-IUM DIBROMIDE
1-[(1S,2S,4S,5S,7S,10R,11S,13S,14R,15S)-5,14-bis(acetyloxy)-2,15-dimethyl-4-(1-methylpiperidin-1-ium-1-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-13-yl]-1-methylpiperidin-1-ium
1-[(1S,2S,4S,5S,7S,10R,11S,13S,14R,15S)-5,14-bis(acetyloxy)-2,15-dimethyl-4-(1-methylpiperidin-1-ium-1-yl)tetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadecan-13-yl]-1-methylpiperidin-1-ium
1,1'-((2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3,17-diacetoxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-2,16-diyl)bis(1-methylpiperidin-1-ium) bromide
1,1'-([2beta,3alpha,5alpha,16beta,17beta]-3,17-Bis[acetyloxy]androstane-2,16-diyl)bis(1-methylpiperidinium) dibromide
1,1'-(3,17-Bis(acetyloxy)androstane-2,16-diyl)bis(1-methylpiperidinium) dibromide
1,1'-(3alpha,17beta-Bis(acetyloxy)-5alpha-androstane-2beta,16beta-diyl)bis(1-methylpiperidinium) dibromide
1,1'-(3alpha,17beta-Dihydroxy-5alpha-androstan-2beta,16beta-ylene)bis(1-methylpiperidinium) dibromide diacetate
1,1'-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(Acetyloxy)androstane-2,16-diyl]bis(1-methylpiperidinium) dibromide
1,1'-[2 beta,3alpha,5alpha,16 beta,17 beta)-3,17-bis(acetyloxy)-androstane-2,16-diyl]bis[1-methylpiperidinium] dibromide
15500-66-0
16974-53-1
2beta,16beta-Dipiperidino-5alpha-androstane-3alpha,17beta-diol diacetate dimethobromide
2beta,16beta-Dipiperidino-5alpha-androstane-3alpha,17beta-dioldiacetatedimethobromide
3-alpha,17-beta-Diacetoxy-2-beta,16-beta-dipiperidino-5-alpha-androstane dimethobromide
3alpha,17beta-diacetoxy-2beta,16beta-bis(1-methylpiperidinium-1-yl)-5alpha-androstane
3alpha,17beta-diacetoxy-2beta,16beta-bis(1-methylpiperidinium-1-yl)-5alpha-androstane dibromide
3alpha,17beta-Diacetoxy-2beta,16beta-dipiperidino-5alpha-androstane dimethobromide
500P660
5alpha-Androstan-3alpha,17beta-diol, 2beta,16beta-dipipecolinio-, dibromide, diacetate
AB0013311
AB00384328
AB00384328_11
AB00384328-09
AB00384328-10
AB2000602
AC1L1D1A
AC1L9AWJ
AC1NTUSZ
Ambap15500-66-0
AN-7536
BPBio1_001372
Bromure de pancuronium
Bromure de pancuronium [INN-French]
bromurex
Bromuro de pancuronio
Bromuro de pancuronio [INN-Spanish]
BSPBio_001247
C-54927
C07551
C35H60Br2N2O4
C35H60N2O4
CAS-15500-66-0
CCG-204969
CCG-221034
CCG-222191
CHEBI:7907
CHEBI:7908
CHEMBL1200757
CHEMBL185073
CS-2535
D00492
D0AA0L
DB01337
DSSTox_CID_3415
DSSTox_GSID_23415
DSSTox_RID_77018
DTXSID7048405
DTXSID9023415
EBD2199002
EINECS 239-532-5
EU-0100887
GTPL4001
H857
HMS1571O09
HMS2089M07
HMS2098O09
HMS2231G20
HMS3262B16
HSDB 3244
HY-B0429
J76UF062FS
Lopac0_000887
LP00887
LS-116480
MFCD00079223
Mioblock
MLS000069586
MLS001333694
MolPort-003-938-961
NA 97
NCGC00023037-03
NCGC00023037-04
NCGC00023037-05
NCGC00163232-01
NCGC00261572-01
NSC 293162
NSC293162
ORG NA 97
ORG-NA 97
P 1918
Pancuronii bromidum
Pancuronii bromidum [INN-Latin]
pancuronium
Pancuronium (dibromide)
Pancuronium bromide (JP15/USAN/INN)
Pancuronium bromide (JP17/USAN/INN)
Pancuronium bromide [USAN:BAN:INN:JAN]
Pancuronium bromide [USAN:USP:INN:BAN:JAN]
Pancuronium bromide for system suitability, European Pharmacopoeia (EP) Reference Standard
Pancuronium bromide, European Pharmacopoeia (EP) Reference Standard
Pancuronium bromide, United States Pharmacopeia (USP) Reference Standard
Pancuronium cation
Pancuronium dibromide
Pavulon
Pavulon (TN)
Piperidinium, 1,1'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1-methyl-, dibromide
Piperidinium, 1,1'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1-methyl)-, dibromide
Piperidinium, 1,1'-(2-beta,16-beta-(3-alpha,17-beta-dihydroxy-5-alpha-androstanylene))bis(1-methyl-, dibromide, diacetate
Piperidinium, 1,1'-(3alpha,17beta-dihydroxy-5alpha-androstan-2beta,16beta-ylene)bis(1-methyl-, dibromide, diacetate
Piperidinium, 1,1'-(3alpha,17beta-dihydroxy-5alpha-androstan-2beta,16beta-ylene)bis(1-methyl-, dibromide, diacetate (8CI)
Piperidinium, 1,1'-[(2.beta.,3.alpha.,5.alpha.,16.beta.,17.beta.)-3,17-bis(acetyloxy)androstane-2,16-diyl]bis[1-methyl-, dibromide
PL001054
Poncuronium bromide
Prestwick0_001034
Prestwick1_001034
Prestwick2_001034
Prestwick3_001034
Q-101015
s2497
SC-22780
SCHEMBL13790650
SCHEMBL41185
SMR000058820
SPBio_003098
SR-01000000127
SR-01000000127-3
Tox21_112033
Tox21_500887
U9LY9Y75X2
UNII-J76UF062FS
UNII-U9LY9Y75X2
ZINC4097383

US Patents and Regulatory Information for pancuronium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira PANCURONIUM BROMIDE pancuronium bromide INJECTABLE;INJECTION 072321-001 Jan 19, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Igi Labs Inc PANCURONIUM BROMIDE pancuronium bromide INJECTABLE;INJECTION 072213-001 Mar 31, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira PANCURONIUM BROMIDE pancuronium bromide INJECTABLE;INJECTION 072320-001 Jan 19, 1989 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Elkins Sinn PANCURONIUM BROMIDE pancuronium bromide INJECTABLE;INJECTION 072060-001 Mar 23, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for pancuronium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc PAVULON pancuronium bromide INJECTABLE;INJECTION 017015-002 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Organon Usa Inc PAVULON pancuronium bromide INJECTABLE;INJECTION 017015-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Harvard Business School
Cantor Fitzgerald
Moodys
Chubb
Mallinckrodt
QuintilesIMS
Medtronic
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.